FeesSafety
Pluang+

3.9M LIT tokens worth $12.21M moved to OKX and other exchanges after unstaking

Market News
02 Nov 2026, 14:37 WIB
Tokenpost
View Source
Neutral
3.9M LIT tokens worth $12.21M moved to OKX and other exchanges after unstaking

On November 2, an address starting with 0x14A transferred 3.9 million Lighter (LIT) tokens to OKX and other cryptocurrency exchanges. This transfer occurred two days after the tokens were unstaked, with the total value of the tokens estimated at approximately $12.21 million. Such a large movement of tokens to exchanges may indicate potential selling activity or repositioning by the holder, which could impact the token's market dynamics.

The Lighter (LIT) token transfer is the story's subject, providing context for readers. For those tracking major cryptocurrencies on Pluang, 7 out of 50 rose while 42 fell as of Nov 02, 2026 19:42 WIB. Notable movers include SXP down 46.27% at Rp37, BAL up 11.14% at Rp16.297, and EOS up 8.13% at Rp12.649.

More News

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...

Market News
Bearish
55 minutes ago
Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...

Company Fundamentals
Neutral
55 minutes ago
Alvotech to present at multiple investor conferences in November 2026.

Alvotech to present at multiple investor conferences in November 2026.

Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...

Market News
Neutral
55 minutes ago
Alvotech to present at multiple investor conferences in November 2026

Alvotech to present at multiple investor conferences in November 2026

Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...

Market News
Neutral
55 minutes ago
Alvotech to present at four major investor conferences in November across Europe.

Alvotech to present at four major investor conferences in November across Europe.

Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

Market News
Neutral
55 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App